APK5166 FINAL EXAM PREP

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/63

flashcard set

Earn XP

Description and Tags

Sports Supplements

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

64 Terms

1
New cards

Ursolic Acid

  • Category: Phytochemical (terpenoid)
  • Mechanism: Decreases white adipose tissue, increases brown adipose tissue, increases mTOR, muscle strength, and IGF-1.
  • Research: Implied by stated physiological effects.
  • Effectiveness: Effective in influencing body composition, muscle strength, and growth factors.
  • Protein Synthesis: Directly increases mTOR and IGF-1, promoting protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
2
New cards

Ecdysterone

  • Category: Phytochemical (terpenoid)
  • Mechanism: Possesses a similar structure to androgenic steroids, increasing anabolic effects by inhibiting estrogen receptors.
  • Research: Currently part of the WADA monitoring program as of 2023.
  • Effectiveness: Shown to increase anabolic effects.
  • Protein Synthesis: Promotes anabolic effects, indicating increased protein synthesis.
  • Legal Status: Legal, but under WADA monitoring, indicating potential future ban.
3
New cards

Caffeine

  • Category: Phytochemical (alkaloid)
  • Mechanism: Increases fat oxidation and decreases fatigue by antagonizing adenosine receptors.
  • Research: Widely researched and confirmed for performance enhancement.
  • Effectiveness: Improves both aerobic and anaerobic performance.
  • Protein Synthesis: Not a primary mechanism for direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
4
New cards

Capsaicin

  • Category: Phytochemical (alkaloid)
  • Mechanism: Exhibits anti-inflammatory properties by decreasing the total amount of circulating cytokines.
  • Research: Demonstrated to reduce systemic inflammation.
  • Effectiveness: Effective in decreasing circulating cytokines and providing anti-inflammatory benefits.
  • Protein Synthesis: Not a primary mechanism for direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
5
New cards

Sulforaphane

  • Category: Phytochemical (organosulfur compound)
  • Mechanism: Advertised for muscle growth through myostatin suppression.
  • Research: In vitro studies suggest myostatin suppression, but it is not effective for muscle growth in humans.
  • Effectiveness: Not effective for muscle growth in humans.
  • Protein Synthesis: Proposed to promote muscle growth via myostatin suppression, but human efficacy is lacking.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
6
New cards

Resveratrol

  • Category: Phytochemical (Phenolic Compound/Stilbene)
  • Mechanism: Investigated for modest reductions in blood pressure, significant changes in body composition, improvements in glucose metabolism, and promotion of mitochondrial biogenesis.
  • Research: Subject to ongoing research regarding its various physiological effects.
  • Effectiveness: Shows modest reductions in blood pressure and significant changes in body composition, glucose metabolism, and mitochondrial biogenesis.
  • Protein Synthesis: Indirectly related to body composition changes and mitochondrial health, but not a direct activator of protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
7
New cards

Curcumin

  • Category: Phytochemical (Phenolic compound/curcuminoid)
  • Mechanism: Possesses anti-inflammatory properties.
  • Research: Used in studies for post-workout recovery.
  • Effectiveness: Effective in reducing fatigue and muscle soreness after a workout due to its anti-inflammatory properties.
  • Protein Synthesis: Not a primary mechanism for direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
8
New cards

Quercetin

  • Category: Phenol (flavonoid)
  • Mechanism: Proposed to act as an anti-cancer agent, increase mitochondria, and decrease fatigue.
  • Research: Proposed biological activities, but performance improvement in humans is minimal and not statistically significant.
  • Effectiveness: Performance improvement is minimal and not significant.
  • Protein Synthesis: Not a primary mechanism for direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
9
New cards

Caralluma fimbriata extract

  • Category: Weight-loss (appetite suppressing) supplement
  • Mechanism: Increases the release of orexin and promotes lipolysis.
  • Research: Implied by the proposed mechanisms.
  • Effectiveness: Not effective for weight loss.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal, but ineffective.
10
New cards

Fucoxanthin

  • Category: Weight-loss (appetite suppressing) supplement
  • Mechanism: Alters leptin activity to increase the feeling of satiety.
  • Research: Demonstrated to be clinically significant in studies.
  • Effectiveness: Clinically significant for increasing satiety.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
11
New cards

Rimonabant

  • Category: Prescription weight-loss medication (selective CB1 receptor blocker)
  • Mechanism: Decreases appetite by selectively blocking CB1 receptors.
  • Research: Clinically significant for weight loss.
  • Effectiveness: Clinically significant but associated with severe mood changes. No longer available due to side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Not legal in supplements; previously a prescription drug, now off-market.
12
New cards

Hoodia Gordonii

  • Category: Weight-loss (appetite suppressing) supplement
  • Mechanism: Acts as an appetite suppressant (specific mechanism not fully established).
  • Research: Lacks meta-analysis or substantial human trials to prove effectiveness.
  • Effectiveness: Not proven effective, with possible cardiovascular side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal, but effectiveness is unsubstantiated and potential side effects exist.
13
New cards

Orlistat

  • Category: Weight-loss medication
  • Mechanism: Decreases the absorption of lipids by blocking lipase function orally and in the GI tract.
  • Research: Clinically significant for weight loss.
  • Effectiveness: Clinically significant, but causes severe gastrointestinal issues.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Not legal in supplements; prescription drug.
14
New cards

White Bean Extract (Phase 2)

  • Category: Weight-loss supplement
  • Mechanism: Decreases the absorption of carbohydrates by blocking amylase function.
  • Research: Demonstrated to be clinically significant.
  • Effectiveness: Clinically significant with no reported side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
15
New cards

Chitosan

  • Category: Weight-loss supplement (soluble fiber)
  • Mechanism: Decreases the absorption of lipids.
  • Research: Demonstrated to be clinically significant.
  • Effectiveness: Clinically significant with no reported side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
16
New cards

Green Tea Extract

  • Category: Weight-loss supplement
  • Mechanism: Decreases the absorption of lipids due to the presence of tea tannins.
  • Research: Demonstrated to be clinically significant.
  • Effectiveness: Clinically significant, but with few reported cases of liver toxicity.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
17
New cards

Glucomanan

  • Category: Weight-loss supplement (soluble fiber)
  • Mechanism: Decreases the absorption of lipids.
  • Research: Demonstrated to be clinically significant.
  • Effectiveness: Clinically significant with minimal bloating side effects, but appears less effective than chitosan.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
18
New cards

Chromium

  • Category: Weight-loss trace mineral
  • Mechanism: Increases Basal Metabolic Rate (BMR) by improving insulin receptor activity, leading to increased lipolysis and glucose metabolism.
  • Research: Clinically significant, but primarily effective in chromium-deficient individuals.
  • Effectiveness: Clinically significant, but seemingly only in individuals with chromium deficiency.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
19
New cards

Cayenne Pepper Extract

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR) through increased lipolysis.
  • Research: Demonstrated to be clinically significant for BMR.
  • Effectiveness: Clinically significant for a small increase in BMR, but not for overall weight loss. Side effects include flushing and heartburn.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
20
New cards

Grains of Paradise Seed

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR) through its active ingredient, 6-paradol, which causes increased lipolysis.
  • Research: Effective for BMR and visceral fat based on one human study.
  • Effectiveness: Effective for BMR and reduction of visceral fat based on limited research (one study).
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
21
New cards

Green Coffee Bean Extract

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR) and is proposed to improve glucose metabolism.
  • Research: Demonstrated to be clinically significant for a modest amount of weight loss.
  • Effectiveness: Clinically significant for a small amount of weight loss, with similar side effects to caffeine.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
22
New cards

Raspberry Ketones

  • Category: Weight-loss supplement
  • Mechanism: Proposed to increase Basal Metabolic Rate (BMR) and improve lipolysis.
  • Research: No significant human studies confirm its effectiveness.
  • Effectiveness: Not confirmed effective in human studies.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal, but unproven effectiveness.
23
New cards

Garcinia Cambogia

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR) through hydroxycitric acid, leading to increased lipid metabolism.
  • Research: Demonstrated effectiveness for weight loss.
  • Effectiveness: Effective for weight loss, but with significant side effects including potential hepatic failure, mania, and hepatitis.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal, but with significant health risks.
24
New cards

Conjugated Linoleic Acid

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR) through improved lipolysis.
  • Research: Demonstrated effectiveness.
  • Effectiveness: Effective with no reported side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
25
New cards

Ephedra

  • Category: Banned weight-loss stimulant
  • Mechanism: Increases Basal Metabolic Rate (BMR).
  • Research: Shows small benefits for weight loss, but with potential stimulant-related side effects.
  • Effectiveness: Small benefits for weight loss, but with severe potential stimulant-related side effects like tremors, psychosis, and cardiac issues.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by regulatory bodies such as the FDA (in supplements), WADA, and NCAA.
26
New cards

Synephrine

  • Category: Weight-loss supplement
  • Mechanism: Increases Basal Metabolic Rate (BMR).
  • Research: Shows modest improvement in weight loss, often studied in combination with caffeine.
  • Effectiveness: Modest improvement in weight loss, with stimulant-related side effects (many studies incorporated caffeine, confounding independent effects).
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal, but acknowledged for its stimulant-like side effects.
27
New cards

Sibutramine

  • Category: Pharmaceutical drug for weight loss
  • Mechanism: Increases Basal Metabolic Rate (BMR) (mechanism of appetite suppression and norepinephrine/serotonin reuptake inhibition).
  • Research: Caused significant weight loss.
  • Effectiveness: Caused significant weight loss but was taken off the market in 2010 due to significant cardiovascular side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Pharmaceutical drug, taken off the market due to safety concerns. Not legal in supplements.
28
New cards

DMAA (Methylhaxanamine)

  • Category: Banned stimulant
  • Mechanism: Increases Basal Metabolic Rate (BMR).
  • Research: Effectiveness for performance or weight loss is unknown.
  • Effectiveness: Effectiveness is unknown, but associated with many stimulant-related side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
29
New cards

DMHA (Octodrine)

  • Category: Banned stimulant
  • Mechanism: Increases Basal Metabolic Rate (BMR).
  • Research: Effectiveness for performance or weight loss is unknown.
  • Effectiveness: Effectiveness is unknown, but associated with many stimulant-related side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
30
New cards

Fenproporex

  • Category: Banned stimulant
  • Mechanism: Increases Basal Metabolic Rate (BMR).
  • Research: Effectiveness for performance or weight loss is unknown.
  • Effectiveness: Effectiveness is unknown, but associated with many stimulant-related side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
31
New cards

Oxandrolone (Anavar)

  • Category: Banned oral anabolic steroid
  • Mechanism: Attaches to androgen receptors, leading to increased mTOR, decreased myostatin, and decreased protein degradation.
  • Research: Studies prior to 1988 showed effectiveness in gaining muscle mass.
  • Effectiveness: Effective in gaining muscle mass based on historical studies.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation, robustly promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
32
New cards

Metandienone (Dianabol)

  • Category: Banned oral anabolic steroid
  • Mechanism: Attaches to androgen receptors to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies prior to 1988 showed effectiveness in gaining muscle mass.
  • Effectiveness: Effective in gaining muscle mass based on historical studies.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation, robustly promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
33
New cards

Nandrolone (Deca Durabolin)

  • Category: Banned injectable anabolic steroid
  • Mechanism: Attaches to androgen receptors to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies prior to 1988 showed effectiveness in gaining muscle mass.
  • Effectiveness: Effective in gaining muscle mass based on historical studies.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation, robustly promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
34
New cards

Trenbolone (Finajet)

  • Category: Banned injectable anabolic steroid
  • Mechanism: Attaches to androgen receptors to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies prior to 1988 showed effectiveness in gaining muscle mass.
  • Effectiveness: Effective in gaining muscle mass based on historical studies.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation, robustly promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
35
New cards

Stanozolol (Winstrol)

  • Category: Banned oral or injectable anabolic steroid
  • Mechanism: Attaches to androgen receptors to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies prior to 1988 showed effectiveness in gaining muscle mass.
  • Effectiveness: Effective in gaining muscle mass based on historical studies.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation, robustly promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
36
New cards

Ostarine (MK-2866)

  • Category: Banned SARM (Selective Androgen Receptor Modulator)
  • Mechanism: Attaches to androgen receptors specifically in bone and muscle tissue to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies in older individuals have shown increases in muscle mass.
  • Effectiveness: Effective in increasing muscle mass in older individuals.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation in target tissues, promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
37
New cards

Ligandrol (LGD-4033)

  • Category: Banned SARM (Selective Androgen Receptor Modulator)
  • Mechanism: Attaches to androgen receptors specifically in bone and muscle tissue to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: Studies in older individuals have shown increases in muscle mass.
  • Effectiveness: Effective in increasing muscle mass in older individuals.
  • Protein Synthesis: Directly increases mTOR and decreases protein degradation in target tissues, promoting protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
38
New cards

Creatine Monohydrate

  • Category: Legal anabolic amino-acid derivative
  • Mechanism: Activates IGF-1 stimulated mTOR increase and is proposed to increase satellite cells.
  • Research: Clinically significant for muscle strength and growth.
  • Effectiveness: Clinically significant with minimal bloating side effects.
  • Protein Synthesis: Activates mTOR, promoting protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
39
New cards

Whey Protein

  • Category: Legal anabolic amino-acid derivative (protein source)
  • Mechanism: Activates mTOR predominantly through the leucine pathway.
  • Research: Clinically significant for muscle protein synthesis compared to control.
  • Effectiveness: Clinically significant for muscle growth and repair with minimal side effects.
  • Protein Synthesis: Directly activates mTOR via leucine, significantly promoting protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
40
New cards

Leucine

  • Category: Legal anabolic amino-acid derivative (Branched-Chain Amino Acid - BCAA)
  • Mechanism: Activates mTOR through the leucine pathway.
  • Research: Demonstrated effectiveness for muscle protein synthesis.
  • Effectiveness: Effective with minimal side effects.
  • Protein Synthesis: Directly activates mTOR, significantly promoting protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
41
New cards

HMB

  • Category: Legal anabolic amino-acid derivative (metabolite of leucine)
  • Mechanism: Activates mTOR through the leucine pathway.
  • Research: Demonstrated effectiveness for muscle protein synthesis and anti-catabolic effects.
  • Effectiveness: Effective with minimal side effects.
  • Protein Synthesis: Activates mTOR, promoting protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
42
New cards

Fortetropin

  • Category: Legal anabolic myostatin-inhibitor
  • Mechanism: Inhibits myostatin, which in turn leads to increased mTOR and satellite cell activity.
  • Research: Demonstrated effectiveness with minimal side effects based on 3 human studies.
  • Effectiveness: Effective in promoting muscle growth and recovery with minimal side effects.
  • Protein Synthesis: Increases mTOR and satellite cells, promoting protein synthesis and muscle regeneration.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
43
New cards

Phosphatidic Acid

  • Category: Legal anabolic mTOR activator
  • Mechanism: Directly stimulates mTOR.
  • Research: No proven effectiveness despite results from a limited meta-analysis.
  • Effectiveness: No proven effectiveness for muscle growth, with minimal reported side effects.
  • Protein Synthesis: Proposed to directly stimulate mTOR, promoting protein synthesis, but human efficacy is unproven.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
44
New cards

Glutamine

  • Category: Legal amino-acid derivative
  • Mechanism: Decreases the FOXO pathway or protein degradation.
  • Research: Not effective for anabolic effects, but seemed effective for weight loss.
  • Effectiveness: Not effective for anabolic effects, but appears effective for weight loss with minimal side effects.
  • Protein Synthesis: Proposed to decrease protein degradation, but not significantly anabolic.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
45
New cards

Betaine

  • Category: Legal anabolic amino-acid derivative
  • Mechanism: Increases mTOR and decreases the FOXO pathway.
  • Research: No proven effectiveness for muscle growth despite results from a limited meta-analysis.
  • Effectiveness: No proven effectiveness for muscle growth, with minimal side effects.
  • Protein Synthesis: Proposed to increase mTOR and decrease protein degradation, thus promoting protein synthesis, but human efficacy is unproven.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
46
New cards

Boron

  • Category: Legal anabolic trace mineral
  • Mechanism: Increases the amount of free testosterone, causing anabolic effects through androgen receptors.
  • Research: Demonstrated effectiveness, but potentially only in individuals with boron deficiencies.
  • Effectiveness: Effective in increasing free testosterone, but potentially only for individuals with boron deficiencies.
  • Protein Synthesis: Anabolic effects mediated through androgen receptors could influence protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
47
New cards

ZMA

  • Category: Legal anabolic trace mineral blend (Zinc, Magnesium, Vitamin B6)
  • Mechanism: Zinc is proposed to increase testosterone levels, leading to anabolic effects.
  • Research: No proven effectiveness for anabolic effects.
  • Effectiveness: No proven effectiveness for anabolic effects, with minimal side effects.
  • Protein Synthesis: Proposed to cause anabolic effects through increased testosterone, but not effectively proven.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
48
New cards

Laxogenin

  • Category: Banned synthetic plant steroid
  • Mechanism: Proposed to attach to androgen receptors to increase mTOR, decrease myostatin, and decrease protein degradation.
  • Research: No human studies to confirm effectiveness.
  • Effectiveness: No human studies confirm effectiveness, and side effects are unknown.
  • Protein Synthesis: Proposed to increase mTOR and decrease protein degradation, thus promoting protein synthesis, but human efficacy is unproven.
  • Legal Status: Banned by WADA/NCAA.
49
New cards

Blood doping

  • Category: Banned endurance procedure
  • Mechanism: Increases red blood cells to achieve a higher oxygen carrying capacity and higher VO_2
  • Research: Proven to be effective for endurance performance.
  • Effectiveness: Effective, but side effects are related to increasing blood viscosity (e.g., increased risk of clotting).
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
50
New cards

HIF Agents

  • Category: Banned endurance red blood cell enhancer
  • Mechanism: Increases the reaction to low oxygen conditions to induce the creation of red blood cells.
  • Research: Effectiveness for performance is unknown.
  • Effectiveness: Effectiveness is unknown.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
51
New cards

GATA Inhibitors

  • Category: Banned endurance red blood cell enhancer
  • Mechanism: Increases the reaction to low oxygen conditions to induce the creation of red blood cells.
  • Research: Effectiveness for performance is unknown.
  • Effectiveness: Effectiveness is unknown.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
52
New cards

GW1516

  • Category: Banned endurance PPAR-Delta activator
  • Mechanism: Increases PGC-1alpha, which in turn leads to increased mitochondria and capillary density.
  • Research: Very effective in animal studies, but human trials were stopped due to massive side effects, including increased tumor risk.
  • Effectiveness: Very effective in animal models, but too dangerous for human use due to significant tumor risk.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA; pharmaceutical development was halted due to severe safety concerns.
53
New cards

AICAR

  • Category: Banned endurance AMPK activator
  • Mechanism: Increases PGC-1alpha, which in turn leads to increased mitochondria and capillary density.
  • Research: Effective for improving glucose sensitivity and fat usage, but not extensively researched for performance enhancement.
  • Effectiveness: Effective for metabolic improvements (glucose sensitivity, fat usage), but its impact on performance is not well-researched.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Banned by WADA/NCAA.
54
New cards

Clenbuterol

  • Category: Banned Beta-2 agonist (WADA categorizes as anabolic)
  • Mechanism: Increases bronchodilation and acts as a sympathomimetic amine.
  • Research: Effective in animals for increasing muscle mass and potentially changing fiber type, but not proven for endurance performance in humans.
  • Effectiveness: Effective in animals for muscle growth, but human endurance performance benefits are unconfirmed.
  • Protein Synthesis: Promotes muscle mass in animal studies.
  • Legal Status: Banned by WADA/NCAA.
55
New cards

Sodium Bicarbonate

  • Category: Legal endurance buffering agent
  • Mechanism: Increases the body's ability to buffer hydrogen ions during high-intensity exercise.
  • Research: Demonstrated effectiveness for high-intensity performance.
  • Effectiveness: Effective, but common side effects include gastrointestinal distress.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
56
New cards

Rhodiola Rosea

  • Category: Legal endurance phytochemical extract
  • Mechanism: Improves sub-maximal substrate utilization and decreases oxidative damage.
  • Research: Effective for reducing oxidative stress and improving Rate of Perceived Exertion (RPE).
  • Effectiveness: Effective in reducing oxidative stress and improving RPE during exercise.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
57
New cards

Cordyceps Sinensis

  • Category: Legal endurance fungus
  • Mechanism: Increases PGC-1alpha, which in turn leads to increased mitochondria and capillary density.
  • Research: Effective in increasing lactate threshold based on two human studies.
  • Effectiveness: Effective in increasing lactate threshold based on limited human research.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
58
New cards

Terminalia Arjuna

  • Category: Legal endurance phytochemical extract
  • Mechanism: Improves vasodilation and sub-maximal substrate utilization.
  • Research: Primarily researched for angina, not shown to be effective for performance enhancement.
  • Effectiveness: Not effective for athletic performance; research mainly focuses on cardiovascular conditions like angina.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
59
New cards

Panax Ginseng

  • Category: Legal endurance phytochemical extract
  • Mechanism: Its only fully defined mechanism of action is increased nitric oxide production.
  • Research: Showed a small improvement in time to fatigue in endurance trials.
  • Effectiveness: Provides a small improvement in time to fatigue during endurance activities.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
60
New cards

Siberian Ginseng

  • Category: Legal endurance phytochemical extract
  • Mechanism: Improves oxidative phosphorylation, resulting in spared glycogen during exercise.
  • Research: No proven effectiveness for performance.
  • Effectiveness: No proven effectiveness for performance, with no known side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
61
New cards

Beet Root Extract

  • Category: Legal endurance phytochemical extract
  • Mechanism: Increases nitric oxide production, leading to vasodilation.
  • Research: Demonstrated effectiveness in improving time-to-fatigue.
  • Effectiveness: Effective in improving time-to-fatigue during endurance activities.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
62
New cards

CoEnzyme Q10

  • Category: Legal endurance supplement
  • Mechanism: Increases oxidative phosphorylation.
  • Research: No proven effectiveness for performance enhancement.
  • Effectiveness: No proven effectiveness for performance with no known side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
63
New cards

Citrulline Malate

  • Category: Legal endurance amino acid derivative
  • Mechanism: Increases nitric oxide production and enhances ammonia clearance.
  • Research: No improvements demonstrated for endurance performance.
  • Effectiveness: No improvements shown for endurance performance, with no known side effects.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.
64
New cards

Glucuronolactone

  • Category: Legal endurance supplement
  • Mechanism: Proposed to decrease fatigue (exact mechanism not well-understood).
  • Research: Effectiveness is unknown due to a lack of sufficient research.
  • Effectiveness: Unknown due to lack of research.
  • Protein Synthesis: Not typically associated with direct protein synthesis.
  • Legal Status: Legal and compliant with FDA/WADA/NCAA regulations.